Trending

#sprc

Latest posts tagged with #sprc on Bluesky

Latest Top
Trending

Posts tagged #sprc

Preview
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders,

#SPRC SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails

www.stocktitan.net/news/SPRC/sci-sparc-subs...

0 0 0 0
Preview
SciSparc Announces 1-for-9 Reverse Share Split SciSparc (Nasdaq: SPRC) will effect a 1-for-9 reverse share split effective at market open on March 4, 2026, reducing issued and outstanding ordinary shares from 5,089,501 to approximately 565,500.The Ordinary Shares will continue trading under the symbol SPRC on Nasdaq on a split-adjusted basis and will receive a new CUSIP: M82618139. The split was approved June 26, 2025; authorized share capital remains 2,000,000,000 Ordinary Shares. Fractional shares will be rounded at the DTC participant level; options and warrants will be adjusted proportionately.

#SPRC SciSparc Announces 1-for-9 Reverse Share Split

www.stocktitan.net/news/SPRC/sci-sparc-anno...

0 0 0 0
Post image

The SPRC invites applications for a 12-month fixed term position as Lecturer (Teaching) in Race, Ethnicity and Postcolonial Studies from 29 April 2026.
shorturl.at/fOW0b
#SPRC #lecturer #raceethnicityandpostcolonialstudies

0 0 0 0
Post image

Episode 2 of Diaspora Diaries Season 2, Awa sits down with scholar Luke de Noronha @lukedenoronha.bsky.social to question what borders really do in our everyday lives.
www.ucl.ac.uk/racism-racia...
#borders #podcast #sprc

1 0 0 0
Preview
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary

#SPRC SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization

www.stocktitan.net/news/SPRC/sci-sparc-succ...

0 0 0 0
Preview
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity SciSparc (Nasdaq: SPRC) signed a definitive agreement to acquire a portfolio of patents, trademarks and know‑how for endoscopic systems and medical cameras, chiefly the MUSE™ single‑use transoral fundoplication device. The Closing is set for March 8, 2026, at which SciSparc will issue ordinary shares that will represent 19.99% of issued and outstanding share capital to Xylo SciSparc plans immediate commercialization after closing, aims to replicate Xylo’s 2019 Greater China licensing model $2.5B in 2024, projected to $3.03B by 2030.

#SPRC SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity

www.stocktitan.net/news/SPRC/sci-sparc-sign...

0 0 0 0
Awakari App

SciSparc receives Nasdaq notice over stockholders’ equity shortfall

#sprc

Origin | Interest | Match

0 0 0 0
Preview
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders,

#SPRC SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects

www.stocktitan.net/news/SPRC/sci-sparc-neur...

0 0 0 0

#SPRC looks good for weed delivery with strong numbers and government support, perfect opportunity to invest.

0 0 0 0

Today’s most cited tickers with positive sentiment (last 24h):

#SLV: 26
#TSLA: 11
#ASTS: 8
#SPRC: 6
#AAPL: 6
#FTEL: 6
#NFE: 6
#BABA: 6
#DD: 5
#SILVER: 5
#CREV: 4
#GLD: 4
#CTB: 4
#MU: 4

0 0 0 0

SciSparc Ltd, #SPRC, stock has been volatile and trending downward recently, with technical indicators giving mostly sell signals, though some short-term volatility could offer trading opportunities.

0 0 0 0

#SPRC looks strong after reporting solid numbers, and its chart is primed for action. A great opportunity to invest.

0 0 1 0

Today’s most cited tickers with positive sentiment (last 24h):

#SLV: 28
#NVDA: 18
#SPY: 15
#SPX: 13
#CREV: 9
#FTEL: 8
#GLD: 7
#SQFT: 6
#HOOD: 6
#BABA: 6
#SIDU: 6
#BTC: 6
#META: 5
#TSLA: 5
#SPRC: 4
#SOPA: 4

0 0 0 0
Preview
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company SciSparc (Nasdaq: SPRC) announced on Dec. 2, 2025 that NeuroThera Labs (TSXV: NTLX), in which SciSparc holds a controlling interest of approximately 75%, signed a non-binding term sheet to acquire a majority stake in an Israeli quantum-enabled bio data analytics company.Under the Term Sheet NeuroThera would acquire 55% equity of the Target Company in exchange for issuing common shares equal to 40% of NeuroThera’s share capital on a non-diluted basis. The Acquisition is subject to due diligence, definitive agreements, corporate and regulatory approvals, and customary closing conditions; there is no assurance the transaction will be completed.

#SPRC SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company

www.stocktitan.net/news/SPRC/sci-sparc-neur...

0 0 0 0
Preview
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary NeuroThera Labs Inc., recently announced the signing of a binding term sheet to

#SPRC SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio

www.stocktitan.net/news/SPRC/sci-sparc-plan...

0 0 0 0
Most Searched, Wednesday November 26, 2025 – Crystal Equity Research

Most searched small-cap stocks, Wed Nov 26th - #HIVE #NVTS #SMX #DVLT #UPWK #CETY #BTBT #DNN #SPRC #RR #UUUU #RMAX #PLRX #ONDS #LAC #GPUS #CLSK #BYND #AEHL - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Preview
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems SciSparc (Nasdaq: SPRC) signed a binding term sheet to acquire a treasury of patents, trademarks and know‑how for innovative endoscopic systems and medical cameras, principally the MUSE™ transoral fundoplication system from Xylo Technologies.Under the term sheet SciSparc will issue upon closing ordinary shares representing 19.99% of issued and outstanding capital (or pre‑funded warrants in lieu). SciSparc plans to pursue exclusive regional distributor partnerships to commercialize MUSE™ across North America, Europe and Latin America. A May 2025 market report values the global GERD device market at $2.5B in 2024, projected to $3.03B by 2030 (CAGR 3.24% 2025–2030).

#SPRC SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems

www.stocktitan.net/news/SPRC/sci-sparc-to-a...

0 0 0 0
Preview
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system (CNS)

#SPRC SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

www.stocktitan.net/news/SPRC/sci-sparc-neur...

0 0 0 0
From the Belly of the Beast   Ep 01  'The Party'
From the Belly of the Beast Ep 01 'The Party' YouTube video by UCL Sarah Parker Remond Centre

What can the history of anti-colonial struggle teach us about the formation & dangers of a new political party?

How can we build political vehicles that avoid liberal identitarianism?

Watch ep 01 of From the Belly of the Beast ⬇️
youtu.be/KX6yM2QDHdc?...

#FromTheBellyOfTheBeast #SPRC #UCL

1 0 0 0
Preview
SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery SciSparc (Nasdaq: SPRC) announced on September 16, 2025 a board resolution to launch an initiative to develop quantum-powered 3D protein modeling for drug discovery, with a focus on neurological and rare diseases.The program will form a dedicated research team, create a wholly owned Israeli subsidiary, collaborate with experts in quantum computing and structural biology, refine quantum algorithms for protein folding and protein-ligand interactions, and seek new intellectual property.

#SPRC SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery

www.stocktitan.net/news/SPRC/sci-sparc-targ...

0 0 0 0
Preview
SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that its

#SPRC SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders

www.stocktitan.net/news/SPRC/sci-sparc-clea...

0 0 0 0
Preview
SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors SciSparc (Nasdaq: SPRC) announced a framework agreement dated October 6, 2025 with AutoMax Motors and SciSparc Merger Sub to mutually terminate the April 10, 2024 Merger Agreement, effective immediately, the PR states.Under the framework, AutoMax will: (1) repay a $4.25 million loan plus 9% per annum interest compounded annually in a single lump sum on January 1, 2028; and (2) repay a $2.0 million loan via $60,000 monthly installments beginning November 20, 2025 with 8% per annum interest compounded annually to each payment date. The PR also states accrued interest of $114,523 (from Feb 24, 2025 to Nov 20, 2025) will be paid at the outset.

#SPRC SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors

www.stocktitan.net/news/SPRC/sci-sparc-ltd-...

0 0 0 0
Trade Alerts, Tuesday September 30, 2025 – Crystal Equity Research

Small-cap stocks gapping up in trading, Tue Sept 30th - #TLIH #SPRC #IBG #EPOW #VALN #SGLY #DPRO #BENG #ADXN #TBN #WOLF #UNFI - More: crystalequityresearch.com/trade-alerts... - #smallcap

0 0 0 0

Just In: ( NASDAQ: #SPRC ) From Web3 to Quantum: Small-Cap Innovators OFAL, SPRC, XXII Lead Market Movers as XHLD Builds Visibility

0 0 0 0
Most Searched, Thursday September 25, 2025 – Crystal Equity Research

Most searched small-cap stocks, Thu Sept 25th - #EOSE #BTBT #LAES #HTXZ #RR #BB #RXRX #HIVE #ONDS #BITF #EVAX #SPRC #DNN #PLUG #PEPG #SBET #QUBT #LAC #IMRX #AEO - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Preview
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery SciSparc (NASDAQ:SPRC), a clinical-stage pharmaceutical company, announced its board's resolution to launch a groundbreaking initiative leveraging quantum computing for 3D protein modeling in drug discovery. The initiative aims to revolutionize structural biology and personalized medicine through enhanced protein structure prediction and interaction analysis.The company plans to establish a dedicated research team and form collaborations with quantum computing and structural biology experts. The program will focus on developing quantum-enabled tools for protein folding prediction, protein-ligand interaction modeling, and accelerated drug discovery, particularly for neurological and rare diseases. SciSparc will incorporate a new Israeli subsidiary to operate this initiative.

#SPRC SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery

www.stocktitan.net/news/SPRC/sci-sparc-reso...

0 0 0 0